# RL-1 Novel Human-derived Bio-artificial Liver Treatment in Patients of HBV Related ACLF

> **NCT04195282** · NA · UNKNOWN · sponsor: **Third Affiliated Hospital, Sun Yat-Sen University** · enrollment: 20 (estimated)

## Conditions studied

- Hepatitis B
- Acute-On-Chronic Liver Failure

## Interventions

- **OTHER:** Plasma exchange
- **OTHER:** RL-1 Novel Human-derived Bio-artificial Liver Treatment

## Key facts

- **NCT ID:** NCT04195282
- **Lead sponsor:** Third Affiliated Hospital, Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12
- **Primary completion:** 2021-12
- **Final completion:** 2021-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2019-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04195282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04195282, "RL-1 Novel Human-derived Bio-artificial Liver Treatment in Patients of HBV Related ACLF". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04195282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*